Showing 9491-9500 of 18069 results for "".
- Early Identification and Intervention in Rheumatoid Arthritis: Bridging Synovial and Gut Immune Pathwayshttps://reachmd.com/news/early-identification-and-intervention-in-rheumatoid-arthritis-bridging-synovial-and-gut-immune-pathways/2475015/Rheumatoid arthritis often goes unrecognized until synovial inflammation has already caused joint destruction, undermining the potential for disease-modifying intervention. In clinical practice, the window between the emergence of auto
- The Cardiovascular Benefits of Plant-Based Nutrition: Insights into the Portfolio Diethttps://reachmd.com/news/the-cardiovascular-benefits-of-plant-based-nutrition-insights-into-the-portfolio-diet/2475011/Interest in plant-based nutrition provides cardiologists and dietitians with viable strategies to reduce cardiovascular morbidity. According to the American Heart Association, the
- Managing Motor Fluctuations in Parkinson's Disease: Emerging Therapies and Research Insightshttps://reachmd.com/news/managing-motor-fluctuations-in-parkinsons-disease-emerging-therapies-and-research-insights/2474988/Managing motor fluctuations in Parkinson's disease remains a central clinical challenge, as neurologists grapple with the limitations of traditional oral regimens and explore continuous subcutaneous infusion therapies like
- Impact of ESUR Guidelines on MRI Imaging for Endometriosishttps://reachmd.com/news/impact-of-esur-guidelines-on-mri-imaging-for-endometriosis/2474958/Variability in MRI imaging for endometriosis contributes to inconsistent diagnoses and hinders patient outcomes, driving a shift toward the ESUR guidelines to standardize protocols and reporting. The complexities of diagnosing endometr
- Innovations Reshaping Orthopedic Surgery: From Femoral Neck Fractures to Advanced Spinal Navigationhttps://reachmd.com/news/innovations-reshaping-orthopedic-surgery-from-femoral-neck-fractures-to-advanced-spinal-navigation/2474961/Innovations in orthopedic surgery are redefining treatment paradigms, especially in managing femoral neck fractures and navigating complex spinal procedures. Advancements in technology have led to significant improvements in surgical precisio
- Exploring Psychedelic Medicine for IBS Reliefhttps://reachmd.com/news/exploring-psychedelic-medicine-for-ibs-relief/2475007/Despite advances in gastroenterology, a significant proportion of patients with irritable bowel syndrome report inadequate relief, leading to increased interest in innovative treatment approaches. Traditional IBS therapies—ranging from
- Evolving Strategies to Prevent Cancer in Inflammatory Bowel Disease: Integrating Therapeutics and Surgeryhttps://reachmd.com/news/evolving-strategies-to-prevent-cancer-in-inflammatory-bowel-disease-integrating-therapeutics-and-surgery/2474985/In inflammatory bowel disease, persistent mucosal injury in ulcerative colitis and Crohn's disease poses a significant cancer risk, yet many clinicians grapple with controlling chronic low-grade inflammation before dysplasia emerges. C
- Advancing Bladder Cancer Treatment: FDA's Impact on Perioperative Durvalumab and Emerging UGN-102https://reachmd.com/news/advancing-bladder-cancer-treatment-fdas-impact-on-perioperative-durvalumab-and-emerging-ugn-102/2474986/Explore the latest advancements in bladder cancer treatment with an in-depth look at the FDA's approval of perioperative durvalumab for muscle-invasive bladder cancer (MIBC) and the anticipated decision on UGN-102 for non-muscle-invasive blad
- Patent Issued for Coya’s IL-2 Technologyhttps://reachmd.com/news/patent-issued-for-coyas-il-2-technology/2474992/Coya Therapeutics has received a new U.S. patent for proprietary methods of producing a highly stable liquid formulation (aldesleukin) of recombinant human interleukin-2 (rhIL-2), according to a press release from the manufacturer.
- Shifting Paradigms: Molecular Targets in IBD for Cancer Preventionhttps://reachmd.com/news/shifting-paradigms-molecular-targets-in-ibd-for-cancer-prevention/2474982/Gastroenterologists face a critical blind spot: young adults with inflammatory bowel disease (aged 20 to 39) are at a growing risk of bowel cancer when chronic inflammation